Feb 7, 2024 04:45PM
Jun 14, 2023 08:00AM
May 23, 2023 08:00AM
May 16, 2023 08:30AM
Apr 26, 2023 08:00AM
Apr 5, 2023 08:00AM
Mar 20, 2023 08:30AM QSAM Biosciences to Provide Updates on its Clinical Trial at the Emerging Growth Conference on Wednesday, March 22, 2023
Mar 8, 2023 08:00AM
Feb 28, 2023 08:00AM
Feb 22, 2023 08:00AM
Jan 23, 2023 08:30AM
Jan 10, 2023 07:00AM
Nov 15, 2022 08:00AM
Oct 26, 2022 08:00AM QSAM Biosciences Adds Rutgers Cancer Institute of New Jersey as Clinical Trial Site To Expand and Advance Study of CycloSam® in the Treatment of Bone Cancer
Aug 16, 2022 08:00AM
Jul 13, 2022 01:32PM
May 17, 2022 08:00AM
Apr 28, 2022 07:00AM
Apr 12, 2022 08:00AM
Mar 9, 2022 04:30PM
Feb 2, 2022 08:30AM QSAM Biosciences Receives Rare Pediatric Disease Designation from FDA for CycloSam in the Treatment of Osteosarcoma
Jan 25, 2022 08:30AM
Dec 1, 2021 09:00AM
Aug 25, 2021 09:00AM
Aug 18, 2021 09:00AM
Aug 11, 2021 09:00AM
May 25, 2021 09:00AM
May 4, 2021 09:00AM QSAM Biosciences Announces Submission of IND Application for CycloSam® with FDA
Apr 28, 2021 09:00AM
Apr 19, 2021 09:00AM
Mar 17, 2021 09:00AM
Feb 16, 2021 09:00AM
Feb 11, 2021 06:08PM
Jan 28, 2021 09:00AM
Jan 21, 2021 09:00AM QSAM Biosciences Receives Favorable Safety Results in Study for its Leading Radiopharmaceutical Drug Candidate
Dec 10, 2020 09:00AM
Nov 24, 2020 09:00AM
Nov 10, 2020 09:00AM
Oct 9, 2020 09:00AM

324,023 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All